## **Core Concept**
The question tests the pharmacokinetic property of plasma protein binding among different opioids. Plasma protein binding is a crucial aspect of drug pharmacokinetics, affecting drug distribution, metabolism, and elimination. Opioids, like many other drugs, can bind to plasma proteins, which influences their availability and activity in the body.

## **Why the Correct Answer is Right**
Fentanyl is known for its high lipid solubility and also has a significant plasma protein binding capacity. Approximately 80-90% of fentanyl is bound to plasma proteins, primarily albumin. This high binding capacity affects its pharmacokinetics and pharmacodynamics, contributing to its potency and duration of action. The high plasma protein binding of fentanyl also means that only a small fraction of the drug is available in the free (unbound) form to exert its effects on the central nervous system.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While morphine does have some degree of plasma protein binding (about 20-35%), it is significantly lower than that of fentanyl. This lower binding capacity means more morphine is available in the free form.
- **Option B:** The plasma protein binding of this opioid is not specified, but given that fentanyl has the highest among the options provided, and without specific details on the other opioids listed, we focus on fentanyl's known high binding capacity.
- **Option D:** Similarly, without specific details on this opioid's plasma protein binding, we rely on the known properties of fentanyl to guide our choice.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the degree of plasma protein binding can affect the onset and duration of action of a drug, as well as its interactions with other highly bound drugs. For highly bound drugs like fentanyl, changes in plasma protein concentration (e.g., in liver or kidney disease) can significantly affect drug levels and efficacy.

## **Correct Answer:** . Fentanyl.